ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $168,000 | -26.6% | 21,600 | -14.3% | 0.00% | -50.0% |
| Q3 2021 | $229,000 | +53.7% | 25,200 | +152.0% | 0.01% | +100.0% |
| Q4 2020 | $149,000 | +40.6% | 10,000 | -45.1% | 0.00% | -33.3% |
| Q2 2020 | $106,000 | -85.8% | 18,200 | -48.8% | 0.01% | -88.0% |
| Q1 2020 | $748,000 | +165.2% | 35,566 | +159.6% | 0.05% | +233.3% |
| Q4 2019 | $282,000 | -58.7% | 13,700 | -90.9% | 0.02% | -73.2% |
| Q3 2019 | $683,000 | +5.9% | 150,500 | -0.3% | 0.06% | +12.0% |
| Q2 2019 | $645,000 | +73.4% | 151,000 | -40.5% | 0.05% | +51.5% |
| Q1 2019 | $372,000 | – | 253,700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |